PT-141

Product Name:

PT-141

Chemical Information:

• Chemical Name: PT-141
• Molecular Formula: C₅₀H₆₈N₁₄O₁₀
• Molecular Weight: 1025.2 g/mol
• Sequence: Ac-Nle-Asp(1)-His-D-Phe-Arg-Trp-Lys(1)-OH

Molecular Structure:

Product Description:

PT-141 is a synthetic cyclic peptide consisting of a defined amino acid sequence. In laboratory environments, it is studied for its chemical stability and peptide behavior under controlled experimental conditions. This product is supplied as a pre-formulated aqueous research solution, intended exclusively for laboratory research use.

Research Applications:

• Investigation of peptide interaction characteristics in vitro
• Study of peptide structural properties and analytical profiles
• Evaluation of peptide stability and degradation pathways
• Comparative research involving synthetic peptide sequences

  Storage and Handling:

• For optimal stability, store sealed product in a cool, dark, and dry environment. Refrigeration at 2–8 °C is recommended after first puncture or once the seal has been compromised
• Do not freeze
• Protect from light
• Handle using aseptic laboratory techniques

Product Specifications:

• Formulation: Aqueous solution
• Concentration: 1 mg/mL
• Total Content: 30 mg per bottle
• Volume: 30 mL
• Delivery Format: Metered liquid solution
• Dispenses per Container: ~200
• Amount per Dispense: ~150 mcg
• Analytical Approach to Finished Formulations: Purity is a metric used for isolated raw materials, such as lyophilized peptide powders. Finished formulations—such as capsules, liquids, and topicals—contain multiple components, including excipients and stabilizers. In these systems, a single purity value does not accurately represent the overall composition. Instead, identity and assay (content) are reported on the COA to confirm the presence of the correct compound and to verify that the labeled amount per unit is accurate. This approach reflects standard analytical practice and provides more meaningful information for research applications

Compliance Notice:

PT-141 is FOR RESEARCH USE ONLY as an analytical reference material. PT-141 is the active ingredient of an FDA-approved pharmaceutical product (Vyleesi®). This research material is not the approved drug product, is not intended for human or veterinary use, and has not been independently evaluated by the FDA as a research compound. Buyers are solely responsible for determining the legality of this compound in their jurisdiction, including compliance with the Federal Analog Act (21 U.S.C. § 813) and any applicable state analog statutes. Misuse of this product is strictly prohibited and may violate federal, state, or local laws. By purchasing this product, buyer represents and warrants that it will be used only for in vitro research purposes.

Product Usage: Not for Human or Veterinary Use

Pure Health Peptides products are supplied to qualified research professionals and institutional users for in vitro laboratory research only. KYC verification is required prior to order fulfillment, and we reserve the right to refuse orders that do not meet buyer qualification criteria. These products are not drugs, foods, cosmetics, diagnostic products, or dietary supplements, have not been evaluated by the FDA, and are not intended for human or animal use. Any such use is prohibited and may violate federal, state, or local law. By purchasing, the buyer represents and warrants that the product will be used solely for in vitro research. The buyer agrees to indemnify, defend, and hold harmless Pure Health Peptides, its officers, employees, and agents from and against any and all claims, damages, losses, liabilities, costs, and expenses (including reasonable attorneys fees) arising out of or relating to the buyer’s use, handling, storage, or disposition of the product in any manner inconsistent with its research-use-only designation or applicable law.